Study at a glance
Why can vitamin D blood results differ between tests and health conditions?
This page asks why a vitamin D blood result can differ between laboratory methods and health conditions. It reviews laboratory research and studies comparing tests. The main measurement is total 25-hydroxyvitamin D, the usual blood marker of vitamin D levels. This total should include the forms made from both vitamin D2 and vitamin D3.
Why did laboratory methods give different vitamin D results?
Some automated tests did not fully measure the form made from vitamin D2. Tests can also differ in how they separate vitamin D from carrier proteins or distinguish it from similar substances. More detailed laboratory methods can separate these forms, but they still need careful checking. Two tests can follow the same pattern while consistently giving different numbers.
Can season, illness and body size affect a vitamin D blood result?
Season, illness, body size and changes in carrier proteins can affect blood measurements. A result may accurately describe the blood sample without describing vitamin D levels over a longer period. A blood result also does not directly measure how vitamin D acts inside tissues.
Do these limits make the usual vitamin D blood test less useful?
Total 25-hydroxyvitamin D remains a useful test, but the laboratory method and the person’s circumstances matter. These limits do not mean that every low result is an error or that routine tests are useless. The evidence does not show that any method removes all uncertainty or that free vitamin D testing should replace total testing for everyone.
Read the full article below ↓A vitamin D blood result looks like a single number, but the number is produced by several layers of biology and measurement. The laboratory must first decide which vitamin D metabolite is being measured, then recover that analyte from binding proteins, distinguish it from related metabolites, calibrate the assay and report a concentration that is interpreted against clinical thresholds. Each layer can introduce limitations. The most widely used status marker, total circulating 25-hydroxyvitamin D [25(OH)D], remains the best general biochemical indicator of vitamin D status, but it is not a direct measurement of vitamin D action in tissues and it is not analytically identical across every method or patient group.
The first limitation is defining the measurand
Vitamin D is not one circulating molecule. Vitamin D3 formed in skin or taken orally is converted to 25(OH)D3, while vitamin D2 from ergocalciferol can produce 25(OH)D2. Both can contribute to vitamin D status, so a total 25(OH)D result should represent the sum of the clinically relevant D2 and D3 25-hydroxy forms. That requirement sounds simple, but it immediately creates an analytical problem: an assay must either measure both forms equimolarly or separate and quantify them before summing them. If it responds differently to 25(OH)D2 and 25(OH)D3, the reported total can depend partly on which form of vitamin D a person receives rather than only on the underlying amount present in circulation.
The measurand is also threatened by structurally related metabolites. The C3 epimer of 25(OH)D3 has the same nominal mass as 25(OH)D3 and can be included in some mass-spectrometric measurements unless chromatography separates it. Conversely, automated immunoassays can show variable cross-reactivity with other vitamin D metabolites. The practical point is not that one platform always reads high and another always reads low. It is that the meaning of “total 25(OH)D” depends on whether the method is actually measuring the intended molecular population.
Binding proteins make extraction part of the measurement
Most circulating 25(OH)D is bound to vitamin D-binding protein and a smaller fraction to albumin; only a very small fraction is free. Routine total-25(OH)D assays therefore have to recover the analyte from its protein-bound state before it can be quantified. Automated assays use proprietary release chemistry. If release from vitamin D-binding protein is incomplete or behaves differently across sample matrices, the result can be biased even when the antibody or detector itself is functioning as designed.
This is one reason matrix effects matter. Serum is not an inert solvent. Concentrations of binding proteins, lipids, albumin and other constituents vary between people and clinical states. Direct automated assays are especially dependent on release and reaction conditions, while chromatography-based methods usually include extraction and separation steps. The analytical problem therefore includes not only detector specificity but also how successfully the assay prepares a biologically complex sample for measurement.
Automated assays trade convenience for some analytical vulnerability
Automated immunoassays are fast, scalable and practical for routine clinical laboratories. Those advantages explain why they remain widely used. They can perform well in many ordinary samples, and modern systems have improved substantially. That is an important counterweight to any claim that immunoassay vitamin D testing is inherently unreliable.
However, method-comparison studies show that acceptable overall correlation does not make assays interchangeable. Bias can remain at concentrations near decision thresholds; different platforms can classify the same sample differently; and recovery of 25(OH)D2 can be substantially weaker than recovery of 25(OH)D3. In a study that challenged two automated assays after a large vitamin D2 dose, measured 25(OH)D2 recovery was markedly incomplete compared with LC-MS/MS. This matters most when ergocalciferol contributes materially to the circulating pool. A person may therefore appear to have a lower total 25(OH)D result because of assay response rather than because all biologically relevant 25-hydroxyvitamin D is absent.
LC-MS/MS is more specific, not infallible
Liquid chromatography-tandem mass spectrometry can distinguish 25(OH)D2 from 25(OH)D3, quantify multiple metabolites and, when appropriately developed, provide higher analytical specificity than most automated immunoassays. It is therefore widely treated as the preferred or reference-oriented approach for complex measurement. But calling LC-MS/MS a gold standard must not be turned into the claim that every LC-MS/MS result is automatically correct.
Mass spectrometry still depends on calibration, extraction, chromatography, internal standards, instrument settings, validation and operator expertise. If the chromatographic system does not resolve isobaric epimers, an analytically specific mass detector can still count the wrong molecular species. Different laboratories can also implement different methods. Standardisation and traceability remain relevant even for LC-MS/MS, and certified reference materials do not substitute for competent method development and quality assurance.
Standardisation reduces variability but does not erase interpretation
International standardisation programmes, reference measurement procedures, NIST materials and external quality-assessment schemes have improved comparability. They are crucial because historical assay drift and between-laboratory differences could change apparent population prevalence of “deficiency” or move individuals across decision thresholds. Standardisation narrows one layer of uncertainty: whether two laboratories are measuring the same intended quantity on a comparable scale.
It cannot solve a different problem: whether the measured circulating quantity is the complete biological answer. A perfectly standardised total 25(OH)D measurement is still a concentration in blood. It does not directly report tissue uptake, local conversion to 1,25-dihydroxyvitamin D, receptor response, intracellular signalling or downstream biological effect. That distinction is central to understanding Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D: choosing the correct metabolite is a separate question from measuring that metabolite accurately.
Physiological variation can change what a circulating concentration represents
Even when the analytical number is correct, the relationship between circulating concentration and the body’s wider vitamin D state can vary. Binding-protein concentration changes in pregnancy, liver disease and protein-losing states can alter the partitioning of total and free vitamin D metabolites. Obesity is associated with lower circulating 25(OH)D concentrations and a smaller rise after equivalent exposure or supplementation, with volumetric dilution among the leading explanations. Acute illness can change fluid distribution, albumin and binding proteins and may alter measured 25(OH)D independently of a simple change in long-term vitamin D input.
These are physiological limitations, not necessarily laboratory errors. An assay can correctly report the concentration present in the specimen while the clinician still misinterprets what that concentration means for longer-term status or functional availability. This is why analytical validity and physiological interpretation must be kept separate.
A single number also contains ordinary biological variation
Circulating 25(OH)D is dynamic. Sun exposure, season, recent supplementation, body composition and changing physiology all contribute to within-person variation. A result taken near the end of summer can represent a different point on an annual trajectory from a result taken near the end of winter. In older adults, one large cohort found a substantial seasonal peak-to-trough difference, large enough for a single measurement to misclassify estimated longer-term exposure.
That issue connects directly with Biological Noise in Vitamin D Testing and Variability in Vitamin D Measurements. The analytical method may be stable while the biology being sampled is moving. Serial results therefore need to be interpreted against both expected biological variation and possible analytical variation rather than treating every numerical change as a true change in underlying physiology.
Why good correlation does not mean interchangeability
Method-comparison studies often report strong correlations between assays. That can sound reassuring, but correlation answers a narrower question than clinical interchangeability. Two methods can rank samples in almost the same order while one reports values systematically higher or lower than the other. If clinical decisions use fixed concentration thresholds, a persistent bias can change classification even when correlation is excellent. Agreement analysis, calibration traceability and performance around medical decision points therefore matter more than a correlation coefficient alone.
This distinction also explains why an assay can be broadly useful at population level yet problematic for an individual near a cut-off or in a sample containing an unusual metabolite mixture. The existence of method limitations should not be exaggerated into universal failure, but neither should good average performance be used to erase clinically relevant outliers or subgroup effects.
What the evidence supports
The strongest evidence supports a layered interpretation. Total 25(OH)D remains the most useful general marker of vitamin D status, but the reported value is conditional on the intended measurand, assay design, extraction from binding proteins, cross-reactivity, metabolite separation, calibration and standardisation. LC-MS/MS usually provides greater specificity and metabolite resolution, but it still requires appropriate chromatography, calibration and laboratory validation. Automated assays can be suitable for routine use but may perform less well in particular sample types, especially where 25(OH)D2 contributes materially.
Above the analytical layer sits a physiological layer. A blood concentration is a circulating compartment measurement, not a direct assay of tissue action. Changes in binding proteins, body size, fluid shifts, illness and season can change the relationship between the measured number and the biological question being asked. The safest interpretation is therefore neither “vitamin D blood tests are useless” nor “the number is the body’s vitamin D truth.” The test is informative when the correct marker, method and clinical context are understood together.
Evidence boundaries
The reviewed evidence does not establish that every low 25(OH)D result is an assay artefact, that immunoassays should never be used, or that free 25(OH)D should routinely replace total 25(OH)D. It also does not show that LC-MS/MS eliminates all uncertainty. Method performance differs by platform and laboratory, and physiological modifiers do not operate identically in every patient. A limitation should therefore be treated as a reason to interpret carefully, not as permission to dismiss an inconvenient result.
Primary source and publication details
Supporting analytical evidence includes Xie Z and colleagues’ method-comparison study of automated immunoassays and LC-MS/MS, and the IFCC position paper on vitamin D metabolite and binding-protein measurement. These were used to test the review’s analytical claims and identify method-specific boundaries rather than to imply that every platform performs identically.
Study Summary
For the shorter reader route, see Circulating Vitamin D Measurements: Physiological and Analytical Limitations: Study Summary.
Related reading
Association of rs2282679 polymorphism in vitamin D binding protein gene (GC) with the risk of vitamin D deficiency in an iranian population: season-specific vitamin D status
We aimed to investigate an association between rs2282679 polymorphism in GC and vitamin D deficiency.
Original paper ↗Read more →Circulating Vitamin D Measurements: Physiological and Analytical Limitations: Study Summary
A concise evidence summary of vitamin D measurement accuracy, assay limitations, metabolite recovery, binding proteins and laboratory method differences.
Read more →Seasonal changes of circulating 25-hydroxyvitamin D correlate with the lower gut microbiome composition in inflammatory bowel disease patients
Higher probability of the development of Crohn’s disease (CD) and ulcerative colitis (UC) as a possible consequence of the north-south gradient has been recently suggested.
Original paper ↗Read more →Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D3 or D2 supplementation
We aimed to investigate the changes of total 25(OH)D, 25(OH)D3 and 25(OH)D2 in a Thai cohort, according to type of vitamin D supplement (vitamin D3 or D2) and DBP genotype, after receiving vitamin D3 or D2 for 3 months.
Original paper ↗Read more →Can the supplementation of vitamin D, sun exposure, and isolation during the COVID-19 pandemic affect the seasonal concentration of 25(OH)D and selected blood parameters among young soccer players in a one-year training season?
Forty elite young soccer players (age: 17.2 ± 1.16 years, body mass: 70.2 ± 5.84, and body height: 179.1 ± 4.26 cm) participated in the research.
Original paper ↗Read more →Cardiovascular disease outcomes in relation to 25-hydroxyvitamin D and its seasonal variation: Results from the BiomarCaRE consortium
The present study examined the association between CVD and (i) seasonality of 25-hydroxyvitamin D (25[OH]D) and (ii) individual 25(OH)D concentrations.
Original paper ↗Read more →Changes of 25(OH)D Concentration, Bone Resorption Markers and Physical Performance as an Effect of Sun Exposure, Supplementation of Vitamin D and Lockdown among Young Soccer Players during a One-Year Training Season
The main purpose of this research was to demonstrate the changes in 25(OH)D concentration, bone resorption markers, and physical fitness along the one-year training season in young soccer players.
Original paper ↗Read more →Do Serum 25-Hydroxyvitamin D Concentrations Affect Body Composition, Physical Fitness, Bone Strength and Bone Biomarkers in Female Children and Adolescent Football Players? A One-Season Study
The aim was to compare changes in body composition, physical fitness, and bone biomarkers in female children and adolescent football players with different Vitamin D levels.
Original paper ↗Read more →Lack of significant seasonal association between serum 25(OH)D concentration, muscle mass and strength in postmenopausal women from the D-FINES longitudinal study
The aim of the present study was to assess the seasonal relationship between serum 25(OH)D concentration, lean mass and muscle strength.
Original paper ↗Read more →Real-life use of vitamin D3-fortified bread and milk during a winter season: the effects of CYP2R1 and GC genes on 25-hydroxyvitamin D concentrations in Danish families, the VitmaD study
Participants were allocated to either vitamin D3-fortified bread and milk or non-fortified bread and milk during winter.
Original paper ↗Read more →Seasonal 25-hydroxyvitamin D levels in new childhood-onset SLE: associations with disease activity and peripheral lymphocyte subsets
All participants were divided into a winter-spring group and a summer-autumn group according to sampling seasons.
Original paper ↗Read more →Seasonal Epidemiology of Serum 25-Hydroxyvitamin D Concentrations among Healthy Adults Living in Rural and Urban Areas in Mongolia
Many factors put Mongolians at risk of vitamin D deficiency.
Original paper ↗Read more →Seasonal variability of serum 25-hydroxyvitamin D on multiple sclerosis onset
This study examines the relationship between serum 25-hydroxyvitamin D (25(OH)D) levels and age of first symptom onset among recently diagnosed MS patients.
Original paper ↗Read more →Seasonal Variation in 25(OH)D at Aberdeen (57°N) and Bone Health Indicators: Could Holidays in the Sun and Cod Liver Oil Supplements Alleviate Deficiency?
The aim of this longitudinal study, was to assess predictors of seasonal variation of 25-hydroxy-vitamin D (25(OH)D) (including use of supplements and holidays in sunny destinations) at a northerly latitude in the UK (57°N) in relation to bone health indicators.
Original paper ↗Read more →Seasonal variation of 25-Hydroxyvitamin D and indices of carbohydrate and lipid metabolism in postmenopausal women
Therefore, the purpose of this study was to evaluate the level of carbohydrate and lipid metabolism indices in relation to seasonal changes in 25-hydroxyvitamin D (25(OH)D) concentration in postmenopausal women.
Original paper ↗Read more →Seasonal variation of idiopathic benign paroxysmal positional vertigo correlates with serum 25-hydroxyvitamin D levels: a six-year registry study in Shanghai, China
Seasonal variation of benign paroxysmal positional vertigo (BPPV) occurrence has been reported in recent years.
Original paper ↗Read more →Seasonal Variations in 25-Hydroxyvitamin D Levels among Pediatric Patients Attending the Healthcare Centre
This study aimed to investigate the seasonal influence on the pediatric circulating levels of 25(OH)D.
Original paper ↗Read more →Serum 25-Hydroxyvitamin D Concentrations and Season-Specific Correlates in Japanese Adults
We investigated the association between lifestyle and serum vitamin D concentration by season in Japanese workers.
Original paper ↗Read more →Maternal and Neonatal Vitamin D Binding Protein Polymorphisms and 25-Hydroxyvitamin D Cutoffs as Determinants of Neonatal Birth Anthropometry
Our aim was to assess the combined effect of maternal and neonatal VDBP polymorphism heterogeneity in conjunction with different maternal and neonatal 25(OH)D cutoffs on the neonatal anthropometric profile at birth.
Original paper ↗Read more →Vitamin D-Binding Protein, Bioavailable, and Free 25(OH)D, and Mortality: A Systematic Review and Meta-Analysis
Introduction: Observational studies reported inverse associations between serum total 25-hydroxyvitamin D (25(OH)D) concentrations and mortality.
Original paper ↗Read more →Vitamin D Binding Protein Genotype Is Associated with Serum 25-Hydroxyvitamin D and PTH Concentrations, as Well as Bone Health in Children and Adolescents in Finland
We examined the role of GC genotypes in S-25(OH)D status and BMD in 231 Finnish children and adolescents aged 7−19 yr.
Original paper ↗Read more →Original sources
Read the full study
Dirks NF, Cavalier E, Heijboer AC.
Publication details
Dirks NF, Cavalier E, Heijboer AC. Vitamin D: marker, measurand & measurement. Endocrine Connections. 2023;12(4):e220269. PMID: 36688810. PMCID: PMC10083657. DOI: 10.1530/EC-22-0269. Read the full study.